Maggie Fettis-Koenders
Senior Scientist II, Synthetic Molecules CMC R&D, Development Sciences Abbvie
Maggie Fettis-Koenders specializes in accelerating drug substance process development from First-in-Human to commercialization. With a background rooted in ADC discovery, she transitioned into ADC process design, bringing unique technical perspectives. Her expertise bridges the critical gap between early-stage discovery and robust DS manufacturing. At AbbVie, she remains dedicated to streamlining complex processes to deliver innovative, life-changing medicines to patients.
Seminars
Wednesday 14th October 2026
Investigating Best Technologies & Methods to Scale Up Process From Lab to GMP Across ADC Formats
2:30 pm
- Breaking down methods to optimize ADC process unit operations to scale from lab to GMP
- Leveraging computational fluid dynamics and kinetic modeling to derisk and optimize ADC process across scales
- Adapting ADC processes to address challenges in solubility and other unique CQA’s found in novel ADCs
